Many of the mediators that regulate airflow in healthy individuals and that contribute to altered airway physiology in patients with pulmonary diseases signal through G protein coupled receptors. These receptors include not only the acetylcholine responsive muscarinic receptors of the parasympathetic pathways but also receptors for a number of inflammatory mediators. Increased production of eicosanoids, lipid mediators derived from arachidonic acid, is observed in virtually all airway diseases. In particular, the inflamed lung produces substantial quantities of thromboxane A2 (TXA2). Thromboxane activates a single GPCR Tp receptor that is broadly expressed in the lung. The mechanism(s) by which inflammatory mediators such as thromboxane contribute to altered airway physiology, in particular the development of hyperresponsive airways, is not well understood. Even less information is available concerning synergism between these inflammatory mediators and neuronal pathways that regulate airway smooth muscle tone in the healthy airway. TXA2 is a potent mediator of both bronchoconstriction and bronchial hyperreactivity in humans. The mechanism by which TXA2 mediates these actions is not well understood. The prevailing view is that TXA2, similar to other eicosanoids, regulates bronchial tone through direct, receptor-mediated effects on smooth muscle. However, based on our preliminary experiments, we suggest an alternative hypothesis: TXA2 regulates airway resistance in a complex manner that integrates direct actions on smooth muscle and indirect actions mediated by stimulating or amplifying specific cholinergic pathways or by altering mediator release by epithelial cells. In this application, we will test these hypotheses and determine the relative contributions of these distinct pathways for regulating airway resistance in the normal lung and during inflammation. Understanding of the interactions between the inflammatory Tp activated pathways and the cholinergic pathways that regulate airway tone will help define the events that lead to increased airway hyperresponsiveness and airway obstruction ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL080697-02
Application #
7171523
Study Section
Special Emphasis Panel (ZRG1-RES-C (02))
Program Officer
Croxton, Thomas
Project Start
2006-02-01
Project End
2010-01-31
Budget Start
2007-02-01
Budget End
2008-01-31
Support Year
2
Fiscal Year
2007
Total Cost
$352,796
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Genetics
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Cyphert, Jaime M; Allen, Irving C; Church, Rachel J et al. (2012) Allergic inflammation induces a persistent mechanistic switch in thromboxane-mediated airway constriction in the mouse. Am J Physiol Lung Cell Mol Physiol 302:L140-51
Duangdao, Dee M; Clark, Stewart D; Okamura, Naoe et al. (2009) Behavioral phenotyping of neuropeptide S receptor knockout mice. Behav Brain Res 205:1-9
Cyphert, Jaime M; Kovarova, Martina; Allen, Irving C et al. (2009) Cooperation between mast cells and neurons is essential for antigen-mediated bronchoconstriction. J Immunol 182:7430-9
Hua, Xiaoyang; Kovarova, Martina; Chason, Kelly D et al. (2007) Enhanced mast cell activation in mice deficient in the A2b adenosine receptor. J Exp Med 204:117-28
Allen, Irving C; Pace, Amy J; Jania, Leigh A et al. (2006) Expression and function of NPSR1/GPRA in the lung before and after induction of asthma-like disease. Am J Physiol Lung Cell Mol Physiol 291:L1005-17